Switch to:

Castle Biosciences Other Long-Term Liabilities

: $-0.00 Mil (As of Jun. 2020)
View and export this data going back to 2019. Start your Free Trial

Castle Biosciences's other long-term liabilities for the quarter that ended in Jun. 2020 was $-0.00 Mil.

Castle Biosciences's quarterly other long-term liabilities declined from Dec. 2019 ($-0.00 Mil) to Mar. 2020 ($-0.00 Mil) but then increased from Mar. 2020 ($-0.00 Mil) to Jun. 2020 ($-0.00 Mil).

Castle Biosciences's annual other long-term liabilities increased from Dec. 2017 ($0.52 Mil) to Dec. 2018 ($1.19 Mil) but then declined from Dec. 2018 ($1.19 Mil) to Dec. 2019 ($-0.00 Mil).


Castle Biosciences Other Long-Term Liabilities Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Castle Biosciences Annual Data
Dec17 Dec18 Dec19
Other Long-Term Liabilities 0.00 0.00 0.00

Castle Biosciences Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Other Long-Term Liabilities Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Castle Biosciences Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.


Castle Biosciences Other Long-Term Liabilities Related Terms


Castle Biosciences Other Long-Term Liabilities Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)